Neuehealth Inc NEUE

$6.73 -0.02 (-0.34%)

Valuation

Market cap
60,940,000
Revenue TTM
$936,660,000
Net income TTM
$-134,680,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-14.38%
Debt to equity
-0.16

Trading

Volume
180
Avg volume
6,476
Day's range
$6.73 – $6.73
Shares out
9,024,000
Stochastic %K
50%
Beta
0.59
Analysts
Moderate Sell
Price target
$7.00

Price

Company profile

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates in two segments, NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health and Premier Medical Associates...

Show more

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates in two segments, NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health and Premier Medical Associates brand names. This segment also offers integrated system care solutions, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

Industry
Healthcare Plans
Sector
Healthcare
Phone
612 238 1321
Website
https://www.neuehealth.com
Address
9250 NW 36th St, Suite 420, Doral, United States

Latest news

No headlines yet.